Global Viral Vectors and Plasmid DNA Manufacturing Market Insights and Forecast to 2031

Report ID: 1200397 | Published Date: Sep 2024 | No. of Page: 114 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Plasmid DNA
        1.2.3 Viral Vectors
    1.3 Market by Application
        1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancers
        1.3.3 Inherited Disorders
        1.3.4 Viral Infections
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2017-2028)
    2.2 Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
        2.2.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2017-2022)
        2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2023-2028)
    2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
        2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
        2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
        2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
        2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue
        3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2017-2022)
        3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2017-2022)
    3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
    3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
        3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2021
    3.5 Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Area Served
    3.6 Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
    3.7 Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
    4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2017-2022)
    4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2023-2028)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
    5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2017-2022)
    5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
    6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
        6.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
        6.2.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
        6.2.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
    6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
        6.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
        6.3.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
        6.3.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
    6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
        6.4.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
        6.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
    7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
        7.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
        7.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
        7.2.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
    7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
        7.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
        7.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
        7.3.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
    7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
        7.4.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
        7.4.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
    8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
        8.2.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
        8.3.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region
        8.4.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
    9.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
        9.2.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
        9.2.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
        9.2.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
    9.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
        9.3.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
        9.3.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
        9.3.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
    9.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
        9.4.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
        9.4.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2017-2028)
    10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
        10.2.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
        10.3.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country
        10.4.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 BioReliance
        11.1.1 BioReliance Company Details
        11.1.2 BioReliance Business Overview
        11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.1.5 BioReliance Recent Developments
    11.2 Cobra Biologics
        11.2.1 Cobra Biologics Company Details
        11.2.2 Cobra Biologics Business Overview
        11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.2.5 Cobra Biologics Recent Developments
    11.3 Oxford BioMedica
        11.3.1 Oxford BioMedica Company Details
        11.3.2 Oxford BioMedica Business Overview
        11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.3.5 Oxford BioMedica Recent Developments
    11.4 UniQure
        11.4.1 UniQure Company Details
        11.4.2 UniQure Business Overview
        11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.4.5 UniQure Recent Developments
    11.5 FinVector
        11.5.1 FinVector Company Details
        11.5.2 FinVector Business Overview
        11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.5.5 FinVector Recent Developments
    11.6 MolMed
        11.6.1 MolMed Company Details
        11.6.2 MolMed Business Overview
        11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.6.5 MolMed Recent Developments
    11.7 MassBiologics
        11.7.1 MassBiologics Company Details
        11.7.2 MassBiologics Business Overview
        11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.7.5 MassBiologics Recent Developments
    11.8 Richter-Helm
        11.8.1 Richter-Helm Company Details
        11.8.2 Richter-Helm Business Overview
        11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.8.5 Richter-Helm Recent Developments
    11.9 FUJIFILM Diosynth Biotechnologies
        11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
        11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
        11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
    11.10 Lonza
        11.10.1 Lonza Company Details
        11.10.2 Lonza Business Overview
        11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.10.5 Lonza Recent Developments
    11.11 Aldevron
        11.11.1 Aldevron Company Details
        11.11.2 Aldevron Business Overview
        11.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.11.5 Aldevron Recent Developments
    11.12 Eurogentec
        11.12.1 Eurogentec Company Details
        11.12.2 Eurogentec Business Overview
        11.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.12.5 Eurogentec Recent Developments
    11.13 Cell and Gene Therapy Catapult
        11.13.1 Cell and Gene Therapy Catapult Company Details
        11.13.2 Cell and Gene Therapy Catapult Business Overview
        11.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.13.5 Cell and Gene Therapy Catapult Recent Developments
    11.14 Biovian
        11.14.1 Biovian Company Details
        11.14.2 Biovian Business Overview
        11.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.14.5 Biovian Recent Developments
    11.15 Thermo Fisher Scientific (Brammer Bio)
        11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
        11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
        11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
    11.16 VGXI
        11.16.1 VGXI Company Details
        11.16.2 VGXI Business Overview
        11.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.16.5 VGXI Recent Developments
    11.17 PlasmidFactory
        11.17.1 PlasmidFactory Company Details
        11.17.2 PlasmidFactory Business Overview
        11.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
        11.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
        11.17.5 PlasmidFactory Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Plasmid DNA
    Table 3. Key Players of Viral Vectors
    Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2017-2022)
    Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2023-2028)
    Table 10. Viral Vectors and Plasmid DNA Manufacturing Market Trends
    Table 11. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
    Table 12. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
    Table 13. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
    Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players (2017-2022)
    Table 16. Global Top Viral Vectors and Plasmid DNA Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2021)
    Table 17. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
    Table 21. Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2017-2022)
    Table 25. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2023-2028)
    Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2017-2022)
    Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Application (2023-2028)
    Table 31. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 61. BioReliance Company Details
    Table 62. BioReliance Business Overview
    Table 63. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product
    Table 64. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 65. BioReliance Recent Developments
    Table 66. Cobra Biologics Company Details
    Table 67. Cobra Biologics Business Overview
    Table 68. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product
    Table 69. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 70. Cobra Biologics Recent Developments
    Table 71. Oxford BioMedica Company Details
    Table 72. Oxford BioMedica Business Overview
    Table 73. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product
    Table 74. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 75. Oxford BioMedica Recent Developments
    Table 76. UniQure Company Details
    Table 77. UniQure Business Overview
    Table 78. UniQure Viral Vectors and Plasmid DNA Manufacturing Product
    Table 79. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 80. UniQure Recent Developments
    Table 81. FinVector Company Details
    Table 82. FinVector Business Overview
    Table 83. FinVector Viral Vectors and Plasmid DNA Manufacturing Product
    Table 84. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 85. FinVector Recent Developments
    Table 86. MolMed Company Details
    Table 87. MolMed Business Overview
    Table 88. MolMed Viral Vectors and Plasmid DNA Manufacturing Product
    Table 89. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 90. MolMed Recent Developments
    Table 91. MassBiologics Company Details
    Table 92. MassBiologics Business Overview
    Table 93. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product
    Table 94. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 95. MassBiologics Recent Developments
    Table 96. Richter-Helm Company Details
    Table 97. Richter-Helm Business Overview
    Table 98. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product
    Table 99. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 100. Richter-Helm Recent Developments
    Table 101. FUJIFILM Diosynth Biotechnologies Company Details
    Table 102. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 103. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product
    Table 104. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 105. FUJIFILM Diosynth Biotechnologies Recent Developments
    Table 106. Lonza Company Details
    Table 107. Lonza Business Overview
    Table 108. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
    Table 109. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 110. Lonza Recent Developments
    Table 111. Aldevron Company Details
    Table 112. Aldevron Business Overview
    Table 113. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product
    Table 114. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 115. Aldevron Recent Developments
    Table 116. Eurogentec Company Details
    Table 117. Eurogentec Business Overview
    Table 118. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product
    Table 119. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 120. Eurogentec Recent Developments
    Table 121. Cell and Gene Therapy Catapult Company Details
    Table 122. Cell and Gene Therapy Catapult Business Overview
    Table 123. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product
    Table 124. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 125. Cell and Gene Therapy Catapult Recent Developments
    Table 126. Biovian Company Details
    Table 127. Biovian Business Overview
    Table 128. Biovian Viral Vectors and Plasmid DNA Manufacturing Product
    Table 129. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 130. Biovian Recent Developments
    Table 131. Thermo Fisher Scientific (Brammer Bio) Company Details
    Table 132. Thermo Fisher Scientific (Brammer Bio) Business Overview
    Table 133. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product
    Table 134. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 135. Thermo Fisher Scientific (Brammer Bio) Recent Developments
    Table 136. VGXI Company Details
    Table 137. VGXI Business Overview
    Table 138. VGXI Viral Vectors and Plasmid DNA Manufacturing Product
    Table 139. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 140. VGXI Recent Developments
    Table 141. PlasmidFactory Company Details
    Table 142. PlasmidFactory Business Overview
    Table 143. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product
    Table 144. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022) & (US$ Million)
    Table 145. PlasmidFactory Recent Developments
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2021 VS 2028
    Figure 2. Plasmid DNA Features
    Figure 3. Viral Vectors Features
    Figure 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2021 VS 2028
    Figure 5. Cancers Case Studies
    Figure 6. Inherited Disorders Case Studies
    Figure 7. Viral Infections Case Studies
    Figure 8. Others Case Studies
    Figure 9. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
    Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2021 VS 2028
    Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2021
    Figure 14. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2021
    Figure 16. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2017-2028)
    Figure 18. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2017-2028)
    Figure 19. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Country (2017-2028)
    Figure 20. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Country (2017-2028)
    Figure 26. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Region (2017-2028)
    Figure 36. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Country (2017-2028)
    Figure 46. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Share by Country (2017-2028)
    Figure 52. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. BioReliance Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 56. Cobra Biologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 57. Oxford BioMedica Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 58. UniQure Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 59. FinVector Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 60. MolMed Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 61. MassBiologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 62. Richter-Helm Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 63. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 64. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 65. Aldevron Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 66. Eurogentec Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 67. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 68. Biovian Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 69. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 70. VGXI Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 71. PlasmidFactory Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Frequently Asked Questions
Viral Vectors and Plasmid DNA Manufacturing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Viral Vectors and Plasmid DNA Manufacturing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Viral Vectors and Plasmid DNA Manufacturing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Egg Incubator

Egg Incubator market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Flu Vaccine

Flu Vaccine market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Divinylbenzene (DVB)

Divinylbenzene (DVB) market is segmented by Type and by Application. Players, stakeholders, and o ... Read More